Table 1 Baseline parameters
Characteristics | Total (n = 22) |
|---|---|
Sex | |
Male | 12 (55%) |
Age | 63 ± 16 years |
Structural heart disease | 13 (59%) |
Coronary artery disease | 9 (41%) |
Dilated cardiomyopathy | 2 (9%) |
Cardiac sarcoidosis | 1 (5%) |
History of myocarditis | 1 (5%) |
Impaired ejection fraction | 12 (55%) |
Mild | 6 (27%) |
Moderate | 4 (18%) |
Severe | 2 (9%) |
PVC-burden in 24 h-Holter | 26.2 ± 15.8% |
Clinical symptoms | |
Dyspnea | 14 (64%) |
Palpitations | 14 (64%) |
Syncope | 1 (5%) |
Cardiovascular risk factors | |
Hypertension | 12 (55%) |
Diabetes mellitus | 4 (18%) |
Chronic kidney disease | 7 (32%) |
Prior myocardial infarction | 5 (23%) |
BMI | 27.4 ± 4.5 |
Prior ventricular ablation | 3 (15%) |
Antiarrhythmic medication | |
Betablocker | 1 (5%) |
Flecainide | 17 (77%) |